Creative Biolabs provides customized support across key stages of lipid-based therapeutic development, helping researchers optimize delivery systems for different types of therapeutic payloads, ...

Namodenoson Holds FDA Fast Track and U.S. and European Orphan Drug Designations; Piclidenoson and Namodenoson Are Advancing in Phase III ...

Generative biology is moving from code to the clinic, promising faster drug discovery while raising hard questions about ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has ...

Artificial intelligence (AI)-based clinical monitoring agents can deliver gains of up to $21m per drug development programme, as well as an 82-times return on investment (ROI), a study has found.

12th August 2026, Aug. 12 -- focused organisation; H.A.B.I.T. Foundation, an initiative promoting entrepreneurship, innovation and industry-academia collaboration; and AIPFC (Association IP ...

Medable Inc., the leading technology platform for agentic clinical development, today announced a new Tufts Center for the Study of Drug Development (CSDD) analysis showing that an AI clinical ...

The biotechnology company now expects full-year revenue between $38.2 billion and $39.4 billion, but said it was halting the ...

JW Pharmaceutical (KRX:001060) announced that the multinational Phase 3 clinical trial of its gout treatment candidate ...

Namodenoson Holds FDA Fast Track and U.S. and European Orphan Drug Designations; Piclidenoson and Namodenoson Are Advancing in Phase III Programs Ramat Gan, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ...

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum ...

Seattle biotech InduPro has raised $77 million and dosed its first patient in a Phase 1 trial of an experimental cancer drug, ...